glutathione and yeast infection Frontiers Frontiers | New antifungal strategies
Description
Receptor binding patterns, intracellular transport mechanisms, and potential off-target effects remain incompletely characterized
Currently, 80% have mild or no symptoms, 20% need hospitalization, and 5% have needed intensive care
PubMed Central , Toxicology Letters , vol
It is generally considered to have a longer-lasting effect than cyanocobalamin
